Publication | Open Access
Antiangiogenic Compound Axitinib Demonstrates Low Toxicity and Antitumoral Effects against Medulloblastoma
17
Citations
39
References
2021
Year
Our results suggest that axitinib is a compelling candidate for MB treatment.
| Year | Citations | |
|---|---|---|
Page 1
Page 1